Saving Lives Through Innovation
The July issue of Psychiatric Times provides insights on clinical challenges and more.
Syuzann q/Adobestock
FROM THE PUBLISHER
A clinician’s job is to cultivate, tend to, and support the mental health of patients—and we recognize your job is admirable and challenging. As we do in all issues of Psychiatric Times™, our job is to bring you the most relevant clinical pearls from the forefront of psychiatry so that you can best support your patients.
This month marks the rollout of 988, the new National Suicide Prevention Lifeline. Although additional funding and logistics may still be under consideration, this system, once perfected, will undoubtedly be a game changer for suicide prevention. How will the system work and how might it affect your practice? We spoke to experts like Christine Yu Moutier, MD, chief medical officer of the American Foundation for Suicide Prevention, and Tony Thrasher, DO, DFAPA, president of the American Association for Emergency Psychiatry, to bring you the most comprehensive first look at this monumental effort.
Based on your feedback, one of the challenging areas in psychiatry is managing psychosis. In Part 2 of our Special Report on this topic, Amy Harrington, MD, and Xiaoduo Fan, MD, MPH, explore methamphetamine-associated psychosis, more relevant than ever with approximately 1.6 million adults using the drug annually. Additionally, Maria Ferrara, MD, shares the specific risks women face for first-episode psychosis, calling for gender-sensitive care. We hope that these articles will aid you in your own practice by providing tools to care for every potential patient.
Our continuing medical education this month reviews the pathophysiology of anti–N-methyl-D-aspartate receptor encephalitis. Through case vignettes that demonstrate potential presentations, Eric Allen Garrels, MD, and colleagues support your understanding of this autoimmune condition down to a cellular level.
From cover to cover, this issue of Psychiatric Times™ shares clinical conversations packed full of the latest research, relevant discussions, and pertinent information to best help you in your job. As always, we have you covered. ❒
Mike Hennessy Jr
President and CEO, MJH Life Sciences®
